Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 17, 2018

Primary Completion Date

March 25, 2025

Study Completion Date

May 31, 2027

Conditions
AscitesParacentesisCirrhosis
Interventions
DEVICE

Alphapump

"Alfapump® device: a completely internalized medical device, implanted under the skin, which mobilizes ascites from the peritoneal cavity to the bladder where they are eliminated by the urinary tract.~Medical device marked CE, used in the indication provided for marking"

PROCEDURE

Ascites puncture

Hospitalizations for evacuating ascites are performed at least twice a month and can be up to 2 times a week. A clinical and biological examination is carried out at each visit.

Trial Locations (10)

25000

RECRUITING

Jean MINJOZ Univesity Hospital, Besançon

31000

RECRUITING

Toulouse University Hospital, Toulouse

33000

NOT_YET_RECRUITING

Haut-Lévêque Hospital, Bordeaux

35000

RECRUITING

Chu Pontchaillou, Rennes

38000

RECRUITING

Grenoble University Hospital, Grenoble

49000

RECRUITING

Chu Angers, Angers

75013

RECRUITING

LA PITIE SALPETRIERE Univesity Hospital, Paris

80000

RECRUITING

Amiens-Picardie University Hospital, Amiens

86000

NOT_YET_RECRUITING

Chu Poitiers, Poitiers

92110

RECRUITING

Beaujon Hospital, Clichy

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT03506893 - Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients | Biotech Hunter | Biotech Hunter